Fangping He

ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

Non-alcoholic fatty liver disease

Deep learning in histopathology: the path to the clinic

Osteoarthritis year in review 2016: genetics, genomics and epigenetics

Osteoarthritis

Inflammation in obesity, diabetes, and related disorders

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Artificial intelligence in prediction of non‐alcoholic fatty liver disease and fibrosis

Protective effects of ex‐527 on cerebral ischemia–reperfusion injury through necroptosis signaling pathway attenuation

Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy

RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF

Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress

Inhibition of receptor-interacting protein 3 upregulation and nuclear translocation involved in Necrostatin-1 protection against hippocampal neuronal programmed necrosis induced by ischemia/reperfusion injury

MicroRNA let-7e Is a Potential Circulating Biomarker of Acute Stage Ischemic Stroke